Waters Completes Combination with BD Biosciences & Diagnostic Solutions
February 9, 2026
Waters Corporation completed its previously announced combination with the Biosciences and Diagnostic Solutions businesses of Becton, Dickinson and Company (BD), creating a global life sciences and diagnostics leader focused on high-volume testing in regulated applications. The deal was executed via a Reverse Morris Trust structure, with BD spinning off the businesses into a separate entity that merged with a wholly owned Waters subsidiary.
- Buyers
- Waters Corporation
- Targets
- BD Biosciences and Diagnostic Solutions (Becton, Dickinson and Company businesses)
- Sellers
- Becton, Dickinson and Company (BD)
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
BD Acquires Edwards Lifesciences' Critical Care Product Group
September 3, 2024
Medical Devices
BD (Becton, Dickinson and Company) completed the acquisition of Edwards Lifesciences' Critical Care product group and has renamed the business BD Advanced Patient Monitoring, based in Irvine, California. The deal expands BD's smart connected care portfolio with advanced monitoring technologies and AI-enabled clinical decision tools, and aligns the new unit within BD's Medical segment to enable integration with BD's infusion platforms and future closed-loop monitoring innovations.
-
Waters Corporation Acquires Halo Labs
May 21, 2025
Medical Devices
Waters Corporation has acquired Halo Labs, a venture-backed developer of the Aura imaging platform for subvisible and visible particle analysis used in cell, gene and protein therapy development and QA/QC. The deal brings Halo Labs' high-throughput, low-volume particle analysis technology into Waters' Wyatt Technology portfolio to expand Waters' analytical and bioprocessing testing capabilities for large-molecule therapies.
-
SD Biosensor and SJL Partners Acquire Meridian Bioscience for $1.53B
July 7, 2022
Medical Devices
A consortium led by SD Biosensor and private equity firm SJL Partners agreed to acquire Meridian Bioscience in an all-cash transaction valued at approximately $1.53 billion ( $34.00 per share). The deal will take Meridian private and is intended to accelerate SD Biosensor's entry into the U.S. in-vitro diagnostics market while leveraging Meridian's U.S. distribution network and product portfolio.
-
MJH Life Sciences Acquires BPD Healthcare
October 22, 2025
Marketing & Advertising
MJH Life Sciences has acquired BPD Healthcare, a tech-enabled marketing and communications partner for health systems and healthcare innovators. The acquisition, completed Oct. 22, 2025 with terms undisclosed, expands MJH's capabilities in data-driven marketing, communications and strategic advisory services; WindRose Health Investors sold its stake in BPD.
-
Sherlock Biosciences Acquires Sense Biodetection
February 1, 2023
Biotechnology
Sherlock Biosciences has acquired Sense Biodetection to accelerate commercialization of CRISPR-enabled, instrument-free molecular diagnostics by integrating Sense’s Veros rapid, instrument-free test platform, chemistry and manufacturing capabilities into Sherlock’s platform. Terms were not disclosed; Sense is headquartered in Oxford, United Kingdom with additional facilities in Cambridge (UK) and Milford, Massachusetts.
-
Integrated Water Services and Sciens Water Acquire M|MBR Systems
January 10, 2023
Environmental Services
Integrated Water Services, in partnership with Sciens Water Opportunities Management, acquired 100% of M|MBR Systems, a membrane bioreactor (MBR) manufacturer and distributor based in Austin, Texas. The deal brings MBR manufacturing, technical expertise and the BluBox modular MBR product under IWS’s umbrella to expand capability and cross-sell solutions across water reuse and wastewater treatment markets in North America.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.